Introduction: Who Should Seek Diagnostic Testing

If you notice certain warning signs in your body, it’s important to talk to your doctor about diagnostic testing. Rectal cancer can develop slowly over many years, often without causing any noticeable symptoms at first. However, some people may experience changes that signal something isn’t right.^[1]

You should consider seeking medical evaluation if you notice rectal bleeding, which can appear as blood in your stool or on toilet paper. Changes in your bowel habits are also important warning signs. This includes experiencing diarrhea or constipation that doesn’t go away, or noticing that your stool looks different than usual—perhaps narrower or shaped like a pencil. Some people also experience a feeling that their bowel doesn’t empty completely after using the bathroom.^[8]

Other symptoms that should prompt a visit to your doctor include unexplained weight loss, persistent tiredness or weakness, and abdominal pain that won’t go away. These symptoms don’t always mean cancer, but they deserve medical attention to find out what’s causing them.^[8]

People with certain risk factors should be particularly attentive to these symptoms. If you have a family history of rectal cancer, have inflammatory bowel diseases like Crohn’s disease or ulcerative colitis, or are over the age of 45, regular screening becomes even more important. Even without symptoms, screening can detect problems early, when they’re easier to treat.^[8]

Diagnostic Methods for Identifying Stage II Rectal Cancer

Once you’ve spoken with your doctor about symptoms or screening, several tests may be used to determine if you have rectal cancer and, if so, what stage it has reached. Stage II rectal cancer means the cancer has grown into the outer layers of the rectal wall or into nearby tissue, but has not spread to lymph nodes or distant organs.^[3]

Physical Examination

Your doctor will likely begin with a digital rectal examination, or DRE. During this exam, the doctor inserts a gloved, lubricated finger into your rectum to feel for any unusual lumps or areas of concern. This simple exam can sometimes detect tumors that are close to the opening of the rectum. While it may feel uncomfortable, it only takes a few moments and can provide valuable information.^[8]

Colonoscopy and Biopsy

A colonoscopy is one of the most important diagnostic tools for rectal cancer. During this procedure, a doctor uses a thin, flexible tube with a camera on the end to look inside your entire rectum and colon. The tube is inserted through the anus, allowing the doctor to see the lining of your bowel on a screen. If the doctor sees anything suspicious, they can take small tissue samples called a biopsy during the same procedure.^[8]

These tissue samples are then sent to a laboratory where a specialist called a pathologist examines them under a microscope. The pathologist can confirm whether cancer cells are present and provide details about the type of cells involved. This information is crucial for determining the best treatment approach.^[8]

Staging Tests: Understanding How Far the Cancer Has Spread

After cancer is confirmed, additional tests are needed to determine the stage. This process is called staging, and it helps your healthcare team understand exactly how far the cancer has grown. Knowing the stage is essential because it guides treatment decisions.^[1]

Doctors commonly use imaging tests to see inside your body without surgery. Blood tests may also be ordered to check your overall health and look for certain markers that can indicate cancer activity. In some cases, imaging alone isn’t enough, and surgery may be needed to get a complete picture of the cancer’s extent.^[1]

The TNM System: A Detailed Look at Staging

Healthcare professionals use a system called TNM to describe cancer in detail. The “T” stands for tumor and describes how deeply the cancer has grown into the rectal wall. The “N” stands for nodes and indicates whether cancer has spread to nearby lymph nodes. The “M” stands for metastasis, which means spread to distant parts of the body.^[1]

In stage II rectal cancer, the cancer has grown through different layers of the rectal wall but has not spread to lymph nodes (N0) or distant organs (M0). Stage II is divided into three subcategories based on how far the tumor has penetrated.^[3]

Stage IIA means the cancer has spread into the outer muscle layer of the rectum called the muscularis propria, but has not grown beyond it. Stage IIB indicates the cancer has grown through the outermost layer of the rectal wall, called the serosa. Stage IIC means the cancer has grown through the rectal wall and into nearby tissues or organs.^[3]

Imaging Scans

Several types of imaging tests help doctors see the tumor and determine whether cancer has spread beyond the rectum. These scans create detailed pictures of your body’s internal structures.^[1]

CT scans (computed tomography) use X-rays and computer technology to create cross-sectional images of your abdomen, pelvis, and chest. These images show the location and size of the tumor and can reveal whether cancer has spread to other organs. CT scans are painless, though you may need to drink a contrast liquid or receive an injection to make the images clearer.^[1]

MRI scans (magnetic resonance imaging) use magnets and radio waves instead of X-rays to create detailed images of soft tissues. MRI is particularly useful for looking at the rectum and surrounding structures. It can show how deeply the tumor has grown into the rectal wall and whether it’s affecting nearby organs.

Ultrasound may also be used, sometimes through the rectum itself in a procedure called transrectal ultrasound. This creates pictures using sound waves and can help doctors see how far the tumor extends into the rectal wall.

Blood Tests

Your doctor may order blood tests to assess your overall health and look for certain markers. One common test measures CEA (carcinoembryonic antigen), a protein that can be elevated in people with colorectal cancer. While CEA levels alone cannot diagnose cancer, they can be useful for monitoring the disease over time. If your CEA level is high before treatment and then drops to normal after treatment, it suggests the treatment was successful. If the level rises again later, it might indicate the cancer has returned.^[8]

Other blood tests check for general health markers like red blood cell counts, which can be low if cancer has caused bleeding, and liver and kidney function tests.

Examining Lymph Nodes

For a diagnosis of stage II rectal cancer, it’s essential to confirm that cancer has not spread to nearby lymph nodes. During surgery or through imaging, doctors examine lymph nodes for any signs of cancer. In stage II disease, the pathology report should indicate that no cancer was found in the lymph nodes, often written as “N0” or “0/X” where X is the number of nodes examined.^[3]

It’s important that enough lymph nodes are examined to be confident about the staging. Medical guidelines generally recommend examining at least 12 lymph nodes to accurately determine whether the cancer has spread to the lymphatic system.

Diagnostics for Clinical Trial Qualification

If you’re considering participating in a clinical trial, additional diagnostic tests may be required beyond those used for standard diagnosis and staging. Clinical trials are research studies that test new treatments or new ways of using existing treatments. They have specific requirements to ensure the study results are accurate and that participants are likely to benefit.^[12]

Before enrolling in a clinical trial for stage II rectal cancer, you’ll typically need comprehensive staging to confirm that your cancer meets the trial’s criteria. This usually includes imaging tests like CT scans or MRI to verify that the cancer has not spread to lymph nodes or distant organs. Some trials may require specific imaging studies or particular types of scans that your doctor may not have ordered during your initial diagnosis.^[12]

Many clinical trials also require detailed tissue analysis from your biopsy. Scientists may look for specific biomarkers—biological characteristics of the tumor that can predict how it will respond to certain treatments. These biomarkers might include genetic mutations or protein expression patterns in the cancer cells. Not all stage II rectal cancers have the same biomarkers, so testing helps match you with trials that are most likely to help.^[12]

Blood tests are often part of clinical trial screening as well. These tests check that your body’s organs, especially your liver and kidneys, are functioning well enough to handle the study treatment. Your blood cell counts also need to be within certain ranges. These requirements help protect your safety during the trial.

Some trials may request a more thorough examination of your overall health, including heart function tests or lung function tests, depending on what treatment is being studied. For example, if a trial involves a drug that could affect the heart, an electrocardiogram or echocardiogram might be required to ensure your heart is healthy enough.

The number of lymph nodes examined during your surgery or biopsy may also be important for trial eligibility. As mentioned earlier, having at least 12 lymph nodes examined helps ensure accurate staging, and many trials require documentation of this to confirm you truly have stage II disease rather than understaged stage III cancer.^[12]

If you’re interested in clinical trials, talk to your doctor about what additional tests might be needed. Your healthcare team can help you understand the requirements and whether a particular trial might be a good fit for your situation. Keep in mind that qualifying for a trial doesn’t mean you must participate—it simply gives you another treatment option to consider.